Frontlight ResearchEarly access
CompletedNo phase
Effects of Esketamine at Subanesthetic Dose on Emergence Delirium in Preschool Children Undergoing Ambulatory Laparoscopic Surgery
Key facts
- Who runs it
- Qiu jinpeng
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 96 people enrolled
- Started
- 7 Feb 2025
- Ended
- 16 May 2025
- Type of study
- Interventional, 3 groupsOne group gets a placebo (a dummy treatment), for comparison.
- Treatments tested
- 0.1mg/kg esketamine
- 0.2mg/kg esketamine
- 0.1ml/kg normal saline
- Record updated
- 22 May 2025
Who can take part
- Age
- 24 months to 71 months
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (10)Hide the full registry criteria
Who can take part
- laparoscopic inguinal hernia repair under general anesthesia
- aged 24~71 months
- American Society of Anesthesiologists Physical Status I or II
- body mass index for age between the 5th and 85th percentiles
Who cannot take part
- allergy to esketamine
- glaucoma or neurological disorders
- asthma or respiratory infection in the last 2 weeks
- abnormal liver or kidney function
- cardiovascular or endocrine dysfunction
- developmental delay
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Emergence delirium (ED) is a manifestation of acute postoperative brain dysfunction that occurs with a relatively high frequency after pediatric anesthesia. The incidence varies depending on the diagnostic criteria used and the combination of administered anesthetic drugs. The goal of this clinical trial is to investigate whether a subanesthetic dose of esketamine can reduce incidence of ED.
The 3 groups in the trial
- group S1 (0.1mg/kg esketamine)Treatment being tested
Treatment: 0.1mg/kg esketamine
- group S2 (0.2mg/kg esketamine)Treatment being tested
Treatment: 0.2mg/kg esketamine
- group C (0.1ml/kg Normal saline)Placebo, for comparison
Treatment: 0.1ml/kg normal saline
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 22 May 2025